. . . . . . . . . "Citalopram, although unlicensed in this age group, was the most popular SSRI, accounting for around 40% of all new prescriptions, followed by fluoxetine at over one-third" . . . . . . "Children and adolescents" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "BA+Q8o0ag0gb9EBbvpPvRRTsYzBFXyooqHi6V5+CgqXkfT1Pe0ZQB3LGYuBs43GBF1yntEopwyL9CfobWN4fHMbcz2DqXEvfyYumzL/bebZebNU2MT0e52vHRdodkjtvTWi1gfFVeVsT6JPl4j6s/JjNldcZ60tymIL0kK36O2c=" . . "2021-05-31T13:00:11.018+02:00"^^ . . . . .